The LPA gene C93T polymorphism influences plasma lipoprotein(a) levels and is independently associated with susceptibility to peripheral arterial disease

Hackam, 2005, Management of risk in peripheral artery disease: recent therapeutic advances, Am Heart J, 150, 35, 10.1016/j.ahj.2005.01.008 Hackam, 2005, Cardiovascular risk prevention in peripheral artery disease, J Vasc Surg, 41, 1070, 10.1016/j.jvs.2005.03.009 Aboyans, 2006, Risk factors for progression of peripheral arterial disease in large and small vessels, Circulation, 113, 2623, 10.1161/CIRCULATIONAHA.105.608679 Grodzińska, 2005, Simvastatin effects in normo- and hypercholesterolaemic patients with peripheral arterial occlusive disease: a pilot study, Basic Clin Pharmacol Toxicol, 96, 413, 10.1111/j.1742-7843.2005.pto_96603.x Vainas, 2006, Synergistic effect of Toll-like receptor 4 and CD14 polymorphisms on the total atherosclerosis burden in patients with peripheral arterial disease, J Vasc Surg, 44, 326, 10.1016/j.jvs.2006.04.035 Libra, 2006, Analysis of G(-174)C IL-6 polymorphism and plasma concentrations of inflammatory markers in patients with type 2 diabetes and peripheral arterial disease, J Clin Pathol, 59, 211, 10.1136/jcp.2004.025452 Pollex, 2005, Methylenetetrahydrofolate reductase polymorphism 677C>T is associated with peripheral arterial disease in type 2 diabetes, Cardiovasc Diabetol, 4, 17, 10.1186/1475-2840-4-17 Eller, 2005, Hepatic lipase polymorphism and increased risk of peripheral arterial disease, J Intern Med, 258, 344, 10.1111/j.1365-2796.2005.01549.x Anuurad, 2006, Lipoprotein(a): a unique risk factor for cardiovascular disease, Clin Lab Med, 26, 751, 10.1016/j.cll.2006.07.002 Deb, 2004, Lipoprotein(a): new insights into mechanisms of atherogenesis and thrombosis, Clin Cardiol, 27, 258, 10.1002/clc.4960270503 Caplice, 2001, Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis, Blood, 98, 2980, 10.1182/blood.V98.10.2980 Scholz, 1999, Genetic control of lipoprotein(a) concentrations is different in Africans and Caucasians, Eur J Hum Genet, 7, 169, 10.1038/sj.ejhg.5200290 Boerwinkle, 1992, Apolipoprotein (a) gene accounts for greater than 90% of the variation in plasma lipoprotein (a) concentrations, J Clin Invest, 90, 52, 10.1172/JCI115855 Brazier, 1999, Sequence polymorphisms in the apolipoprotein(a) gene and their association with lipoprotein(a) levels and myocardial infarction: The ECTIM Study, Atherosclerosis, 144, 323, 10.1016/S0021-9150(98)00333-5 Holmer, 2003, Association of polymorphisms of the apolipoprotein (a) gene with lipoprotein(a) levels and myocardial infarction, Circulation, 107, 696, 10.1161/01.CIR.0000048125.79640.77 Ichinose, 1995, Detection of polymorphisms in the 5'-flanking region of the gene for apolipoprotein(a), Biochem Biophys Res Commun, 209, 372, 10.1006/bbrc.1995.1513 Kraft, 1998, Significant impact of the +93 C/T polymorphism in the apolipoprotein(a) gene on Lp(a) concentrations in Africans but not in Caucasians: confounding effect of linkage disequilibrium, Hum Mol Genet, 7, 257, 10.1093/hmg/7.2.257 Dieplinger, 2007, Increased serum lipoprotein(a) concentrations and low molecular weight phenotypes of apolipoprotein(a) are associated with symptomatic peripheral arterial disease, Clin Chem, 53, 1298, 10.1373/clinchem.2007.088013 Jones, 2007, Plasma lipoprotein(a) indicates risk for 4 distinct forms of vascular disease, Clin Chem, 53, 679, 10.1373/clinchem.2006.079947 Wollesen, 1999, Peripheral atherosclerosis and serum lipoprotein(a) in diabetes, Diabetes Care, 22, 93, 10.2337/diacare.22.1.93 Sofi, 2005, Thrombophilic risk factors for symptomatic peripheral arterial disease, J Vasc Surg, 41, 255, 10.1016/j.jvs.2004.11.015 Zambrelli, 2005, Apo(a) size in ischemic stroke: relation with subtype and severity on hospital admission, Neurology, 64, 1366, 10.1212/01.WNL.0000158282.83369.1D Gaw, 1998, Impact of apo(a) length polymorphism and the control of plasma Lp(a) concentrations: evidence for a threshold effect, Arterioscler Thromb Vasc Biol, 18, 1870, 10.1161/01.ATV.18.12.1870 Milionis, 2003, Lipoprotein (a) levels and apolipoprotein (a) isoform size in patients with subclinical hypothyroidism: effect of treatment with levothyroxine, Thyroid, 13, 365, 10.1089/105072503321669857 Sticchi, 2007, LPA +93C>T and +121G>A polymorphisms detection by electronic microchip technology, Mol Genet Metab, 91, 79, 10.1016/j.ymgme.2006.12.011 Danesh, 2000, Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies, Circulation, 102, 1082, 10.1161/01.CIR.102.10.1082 Smolders, 2007, Lipoprotein (a) and stroke: a meta-analysis of observational studies, Stroke, 38, 1959, 10.1161/STROKEAHA.106.480657 Lupattelli, 1994, Lipoprotein (a) in peripheral arterial occlusive disease, Vasa, 23, 321 Kullo, 2006, A genome-wide linkage scan for ankle-brachial index in African American and non-Hispanic white subjects participating in the GENOA study, Atherosclerosis, 187, 433, 10.1016/j.atherosclerosis.2005.10.003